EXICURE, INC. Revenue from Contract with Customer, Excluding Assessed Tax
EXICURE, INC. (XCUR) reported Revenue from Contract with Customer, Excluding Assessed Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-14
- EXICURE, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $0.00.
- EXICURE, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $0.00.
- EXICURE, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $0.00.
- EXICURE, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $0.00.
- EXICURE, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- EXICURE, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $500.00K.
- EXICURE, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $0.00.
- EXICURE, INC. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $16.61M, a 1181.87% increase from fiscal 2019.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-29 | $0.00 derived: sum of 2 quarters · filed 2026-05-29 | $0.00 derived: sum of 3 quarters · filed 2026-05-29 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-29 | $0.00 derived: sum of 2 quarters · filed 2026-05-29 | $0.00 derived: sum of 3 quarters · filed 2026-05-29 | $0.00 derived: sum of 4 quarters · filed 2026-05-29 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $500.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $500.00K 10-Q · filed 2025-11-07 | $500.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $500.00K 10-Q · filed 2025-08-08 | $500.00K derived: sum of 3 quarters · filed 2025-08-08 | $500.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $500.00K 10-Q · filed 2025-06-27 | $500.00K derived: sum of 2 quarters · filed 2025-06-27 | $500.00K derived: sum of 3 quarters · filed 2025-06-27 | $500.00K derived: sum of 4 quarters · filed 2025-06-27 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $0.00 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-06-17 | |||
| 2021-06-30 | $79.00K 10-Q · filed 2021-08-12 | $1.08M 10-Q · filed 2021-08-12 | $1.22M derived: sum of 3 quarters · filed 2021-08-12 | $3.66M derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | $997.00K 10-Q · filed 2021-05-12 | $1.14M derived: sum of 2 quarters · filed 2021-05-12 | $3.58M derived: sum of 3 quarters · filed 2021-05-12 | $8.43M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-12-31 | $140.00K 10-K · filed 2021-03-11 | $2.58M derived: sum of 2 quarters · filed 2021-03-11 | $7.43M derived: sum of 3 quarters · filed 2021-08-12 | $16.61M 10-K · filed 2021-03-11 |
| 2020-09-30 | $2.44M 10-K · filed 2021-03-11 | $7.29M derived: sum of 2 quarters · filed 2021-08-12 | $16.47M 10-Q · filed 2020-11-12 | $16.78M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-06-30 | $4.85M 10-Q · filed 2021-08-12 | $14.03M 10-Q · filed 2021-08-12 | $14.34M derived: sum of 3 quarters · filed 2021-08-12 | $14.87M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $9.18M 10-Q · filed 2021-05-12 | $9.49M derived: sum of 2 quarters · filed 2021-05-12 | $10.02M derived: sum of 3 quarters · filed 2021-05-12 | $10.45M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $310.00K 10-K · filed 2021-03-11 | $837.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.27M derived: sum of 3 quarters · filed 2021-03-11 | $1.30M 10-K · filed 2021-03-11 |
| 2019-09-30 | $527.00K 10-K · filed 2021-03-11 | $961.00K derived: sum of 2 quarters · filed 2021-03-11 | $986.00K 10-Q · filed 2020-11-12 | $992.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $434.00K 10-K · filed 2021-03-11 | $459.00K 10-Q · filed 2020-08-12 | $465.00K derived: sum of 3 quarters · filed 2021-03-11 | $522.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $25.00K 10-K · filed 2021-03-11 | $31.00K derived: sum of 2 quarters · filed 2021-03-11 | $88.00K derived: sum of 3 quarters · filed 2021-03-11 | $107.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $6.00K 10-K · filed 2020-03-10 | $63.00K derived: sum of 2 quarters · filed 2020-03-10 | $82.00K derived: sum of 3 quarters · filed 2020-03-10 | $118.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | $57.00K 10-K · filed 2020-03-10 | $76.00K derived: sum of 2 quarters · filed 2020-03-10 | $112.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $19.00K 10-K · filed 2020-03-10 | $55.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $36.00K 10-K · filed 2020-03-10 | |||
| 2017-09-30 | $2.50M 10-Q · filed 2018-11-06 | $5.19M derived: sum of 2 quarters · filed 2018-11-06 | $7.62M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $2.69M 10-Q · filed 2018-08-06 | $5.13M 10-Q · filed 2018-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |